Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Divya Bhagirath"'
Autor:
Divya Bhagirath, Michael Liston, Theresa Akoto, Byron Lui, Barbara A. Bensing, Ashok Sharma, Sharanjot Saini
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
Abstract Neuroendocrine prostate cancer (NEPC), a highly aggressive variant of castration-resistant prostate cancer (CRPC), often emerges upon treatment with androgen pathway inhibitors, via neuroendocrine differentiation. Currently, NEPC diagnosis i
Externí odkaz:
https://doaj.org/article/d5214699fc2a4b7883f1e1dd59762ab6
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167064 (2016)
Breast cancer is characterized into different molecular subtypes, and each subtype is characterized by differential gene expression that are associated with distinct survival outcomes in patients. PIK3CA mutations are commonly associated with most br
Externí odkaz:
https://doaj.org/article/df6b699fced2408ab66e7c3eb631fc5c
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Shahana Majid, Z. Laura Tabatabai, Thao Ly Yang, Divya Bhagirath
Fig. S3 EV-associated BRN2 mediates neuroendocrine differentiation states in prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9c9f118d8d8b116823b90db56ea7d2
https://doi.org/10.1158/1078-0432.22472580.v1
https://doi.org/10.1158/1078-0432.22472580.v1
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Varahram Shahryari, Shahana Majid, Kirandeep Sekhon, Nathan Bucay, Thao Ly Yang, Divya Bhagirath
Merged file with following figues: Fig. S1 Characterization of serum exosomal preparations Fig. S2 Biological pathways potentially influenced by dysregulated miRNAsin aggressive PCa as compared to BPH Fig. S3 Exosomal miR-1246 expression patterns dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d5b6ee148e01453d4508cd78882ebbc
https://doi.org/10.1158/0008-5472.22417992
https://doi.org/10.1158/0008-5472.22417992
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Varahram Shahryari, Shahana Majid, Kirandeep Sekhon, Nathan Bucay, Thao Ly Yang, Divya Bhagirath
Because of high heterogeneity, molecular characterization of prostate cancer based on biopsy sampling is often challenging. Hence, a minimally invasive method to determine the molecular imprints of a patient's tumor for risk stratification would be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d169c028d56763e9a0829a0a9f1320c
https://doi.org/10.1158/0008-5472.c.6509997
https://doi.org/10.1158/0008-5472.c.6509997
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Varahram Shahryari, Shahana Majid, Kirandeep Sekhon, Nathan Bucay, Thao Ly Yang, Divya Bhagirath
List of microRNAs significantly dysregulated in A. BPH vs aggressive PCa B. normal vs aggressive PCa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbee413143e22629bf86ddbb8438742
https://doi.org/10.1158/0008-5472.22417986
https://doi.org/10.1158/0008-5472.22417986
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Shahana Majid, Z. Laura Tabatabai, Thao Ly Yang, Divya Bhagirath
Purpose:Neuroendocrine prostate cancer (NEPC), an aggressive variant of castration-resistant prostate cancer (CRPC), often emerges after androgen receptor–targeted therapies such as enzalutamide or de novo, via trans-differentiation process of neur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125e30adad6ad0c15622bfe0f8eff4e7
https://doi.org/10.1158/1078-0432.c.6528267.v1
https://doi.org/10.1158/1078-0432.c.6528267.v1
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Shahana Majid, Z. Laura Tabatabai, Thao Ly Yang, Divya Bhagirath
Fig. S1 Induction of neuroendocrine characteristics upon enzalutamide treatment and/or androgen withdrawal of LNCaP cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f4af4bff174f4e66d767c48d9134fe
https://doi.org/10.1158/1078-0432.22472568
https://doi.org/10.1158/1078-0432.22472568
Autor:
Sharanjot Saini, Yuichiro Tanaka, Rajvir Dahiya, Varahram Shahryari, Shahana Majid, Kirandeep Sekhon, Nathan Bucay, Thao Ly Yang, Divya Bhagirath
Includes supplemental methods, figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8221ca0b086599e1eb956dee93a17bd3
https://doi.org/10.1158/0008-5472.22417989.v1
https://doi.org/10.1158/0008-5472.22417989.v1
Autor:
Rajvir Dahiya, Divya Bhagirath, Z. Laura Tabatabai, Yuichiro Tanaka, Shahana Majid, Thao Ly Yang, Sharanjot Saini
Publikováno v:
Clin Cancer Res
Purpose: Neuroendocrine prostate cancer (NEPC), an aggressive variant of castration-resistant prostate cancer (CRPC), often emerges after androgen receptor–targeted therapies such as enzalutamide or de novo, via trans-differentiation process of neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8335207913532396887fb411b535f240
https://doi.org/10.1158/1078-0432.ccr-19-0498
https://doi.org/10.1158/1078-0432.ccr-19-0498